NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Core Insights - NextCure, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer treatment, particularly for patients who do not respond to existing therapies [3]. Company Participation - NextCure will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference in New York City on September 8 at 4:00 pm ET [1]. Webcast Information - A live audio webcast of the event will be available on the company's website, with a replay accessible for 30 days post-event [2]. Company Overview - NextCure specializes in targeted therapies, including antibody-drug conjugates, and aims to advance treatments by leveraging its expertise in biological pathways and biomarkers [3].